Global Bulimia Nervosa Treatment Market – Restraints
Lack of proper reimbursement policies for the treatment of eating disorders is expected to restrain growth of the global bulimia nervosa treatment market over the forecast period. For instance, according to the National Eating Disorders Associations, per year, in the U.S., the total treatment cost for the eating disorders is valued at US$ 30,000 per patient. Even in the presence of insurance, the patients has to shell out more money for the treatment. Moreover, according to the same source, in the U.S., there were approximately 54,000 emergency department admissions and 23,500 in-patient hospitalizations visits due to eating disorders in the year span of 2018 – 2019, costing around US$ 29 million and US$ 209 million respectively.
Furthermore, lack of drugs specifically for the treatment of bulimia nervosa treatment and lack of awareness regarding the treatment options among the population are the factors that are expected to restrain growth of the global bulimia nervosa treatment market over the forecast period.
Bulimia Nervosa Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients